SCHEMBL5929331

SCHEMBL5929331

CCc1cccc(CC)c1-c1nc(Cl)c(CN2CCCCC2C2CCCCC2)n1C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ CNR1 P21554 1/20 0.32
▸ LTA4H P09960 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ KCNK3 O14649 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ PARP1 P09874 1/20 0.32
▸ TSHR P16473 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ CASP1 P29466 1/20 0.31
▸ BRCA1 P38398 1/20 0.31
▸ CASP7 P55210 1/20 0.31
▸ HBB P68871 1/20 0.31
▸ C5AR1 P21730 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5929060 0.87 CYP3A4 (0.36) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL5929248 0.85 KDM4E (0.33) ALDH1A1MEN1KMT2AKDM4ECNR1
SCHEMBL5929063 0.80 NPSR1 (0.35) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL5928992 0.77 CYP3A4 (0.36) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL5928975 0.76 CNR1 (0.37) MEN1KMT2AKDM4ECNR1LTA4H
SCHEMBL5929059 0.75 KDM4E (0.33) ALDH1A1MEN1KMT2AKDM4ETSHR
SCHEMBL5929057 0.74 CFB (0.43) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL5928890 0.73 KDM4E (0.32) ALDH1A1KDM4ECNR1SLC6A9
SCHEMBL5929000 0.73 CYP3A4 (0.34) ALDH1A1MEN1KMT2AKDM4ECNR1
SCHEMBL5929127 0.73 ALDH1A1 (0.35) ALDH1A1MEN1KMT2AKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators NEUROGEN CORPORATION (US) 2006-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators C5AR1, C5AR2, C3AR1 ALDH1A1 3884/4885MEN1 2791/4885KMT2A 2955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback